Coverage
-
February 25, 2020
A New Jersey federal judge on Tuesday tossed Fresenius Kabi's antitrust suit against Par Pharmaceuticals, which alleged that the drug ingredient maker blocked it from marketing a generic version of an antidiuretic drug.
3 other articles on this case.
View all »